Company Filing History:
Years Active: 1998
Title: Innovations by Stanley T Enomoto
Introduction
Stanley T Enomoto is a notable inventor based in Van Nuys, CA (US). He has made significant contributions to the field of medical technology, particularly in the development of fibrinogen-containing compositions. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
One of his latest patents is a method of preparing a topical fibrinogen complex. This method involves preparing a fibrinogen-containing composition derived from human plasma by separating a cryoprecipitate from the plasma. The process includes suspending the cryoprecipitate in a salt-containing buffer and treating the supernatant by affinity-chromatography on a lysine-bound solid matrix. This allows plasminogen to adsorb, leading to the collection of a fraction containing less than 10 µg/ml plasminogen. The resulting fibrinogen-containing composition is advantageous as it contains a low amount of plasminogen, eliminating the need for additional fibrinolysis inhibitors.
Another significant patent is the topical fibrinogen complex itself. This composition reacts with thrombin to function as a fibrin sealant. It is characterized by being free of detectable levels of lipid enveloped virus activity, prothrombin complex, and active thrombin. Additionally, it contains no protease inhibitors or other non-human proteins. The patent also describes a method for producing this innovative composition.
Career Highlights
Stanley T Enomoto is associated with Baxter International Inc., a leading company in the healthcare sector. His work at Baxter has allowed him to focus on developing advanced medical solutions that enhance patient care and safety.
Collaborations
Throughout his career, Stanley has collaborated with talented individuals such as Daphne C Tse and Samia S Mankarious. These collaborations have contributed to the successful development of his innovative patents.
Conclusion
Stanley T Enomoto's contributions to medical technology through his patents demonstrate his commitment to improving healthcare solutions. His innovative methods for preparing fibrinogen-containing compositions have the potential to significantly benefit medical practices.